Cholesterol Levels in Angiotensin Converting Enzyme Gene Polymorphisms in Schizophrenia Patients

Isra Thristy, Nanda Sari Nuralita, Debby Mirani Lubis

Abstract


Abstract: Angiotensin-converting enzyme (ACE) is widely distributed on the surface of endothelial and epithelial cells. The renin-angiotensin system in the brain has implications for various functions, including cerebral blood circulation and brain protection, stress, depression, and the aetiology of schizophrenia. ACEs and angiotensin receptors can be found on dopaminergic neurons in the basal ganglia. Elevated levels of triglycerides and cholesterol can also be found in schizophrenic patients related to treatment and duration of the course of the disease. The purpose of this study was to determine the relationship between ACE gene polymorphism and cholesterol levels in schizophrenia patients. The design of this study was observational analytic with a cross-sectional approach. The sample in this study was schizophrenia patients who sought treatment at Madani Medan Hospital with a total of 42 people. The data obtained is then processed with the ANOVA one-way test. The results of the study were obtained from 42 samples, the most types of ACE gene polymorphisms were type II (76.2%), followed by the type of DD polymorphism (19%) and the least was the type of ID polymorphism (4.8%). The average value of cholesterol levels of the sample was 235.40 mg/dl with a standard deviation value of 47.618. Statistical test results of ACE gene polymorphism with cholesterol levels with p = 0.770 (p > 0.05). It can be concluded that there is no relationship between the polymorphism of the ACE gene and the cholesterol levels of schizophrenic patients.


Keywords


Angiotensin-converting enzyme (ACE) gene, Cholesterol, Schizophrenia

Full Text:

PDF

References


Cheng H, Wang Y, Wang GQ. Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19. Journal of medical virology. 2020 Jul;92(7):726-30.

Nuralita NS, Thristy I, Lubis DM. Relationship between polymorphism of the angiotensin-converting enzyme gene with symptoms of depression in schizophrenic patients. Buletin Farmatera. 2022 Feb 27;7(1):13-8.

Santiago TC, Parra L, Nani JV, Fidalgo TM, Bradshaw NJ, Hayashi MA. Angiotensin Converting Enzymes as druggable features of psychiatric and neurodegenerative disorders. Journal of Neurochemistry. 2023 Mar 12.

Nadalin S, Dević Pavlić S, Peitl V, Karlović D, Zatković L, Ristić S, Buretić-Tomljanović A, Jakovac H. Association between insertion-deletion polymorphism of the angiotensin-converting enzyme gene and treatment response to antipsychotic medications: a study of antipsychotic-naïve first-episode psychosis patients and nonadherent chronic psychosis patients. International Journal of Molecular Sciences. 2022 Oct 12;23(20):12180.

McCutcheon, R. A., Marques, T. R., & Howes, O. D. 2020. Schizophrenia—an overview. JAMA psychiatry, 77(2), 201-210.

Montes-de-Oca-García A, Perez-Bey A, Velázquez-Díaz D, Corral-Pérez J, Opazo-Díaz E, Rebollo-Ramos M, Gómez-Gallego F, Cuenca-García M, Casals C, Ponce-González JG. Influence of ace gene I/D polymorphism on cardiometabolic risk, maximal fat oxidation, cardiorespiratory fitness, diet and physical activity in young adults. International Journal of Environmental Research and Public Health. 2021 Mar 26;18(7):3443.

Handayani A; Thristy I; Andina M. Association of angiotensin-converting enzyme polymorphism with improved left ventricular ejection fraction in patients with chronic heart failure. Buletin Farmatera, 2021, 6.2: 108-115.

Wójciak P, Domowicz K, Rybakowski JK. Metabolic indices in schizophrenia: association of negative symptoms with higher HDL cholesterol in female patients. The World Journal of Biological Psychiatry. 2021 Aug 9;22(7):552-6.

Meyer T, Rothe I, Staab J, Deter HC, Fangauf SV, Hamacher S, Hellmich M, Jünger J, Ladwig KH, Michal M, Petrowski K. Length polymorphisms in the angiotensin I-converting enzyme gene and the serotonin-transporter-linked polymorphic region constitute a risk haplotype for depression in patients with coronary artery disease. Biochemical genetics. 2020 Aug;58:631-48.

Cholesterol Fs, DiaSys Diagnostic Systems GmbH Alte Strasse 9 65558 Holzheim Germany, 2021.

Technical Manual; Isolating Genomic DNA; Isolating Genomic DNA. Wizard® Genomic DNA Purification Kit. 2019.

Ichsan B; Pengantar metodologi penelitian kedokteran dan kesehatan masyarakat; Muhammadiyah University Press; 2022.

Akbari M, Eghtedarian R, Hussen BM, Eslami S, Taheri M, Ghafouri-Fard S. Angiotensin I converting enzyme gene polymorphisms and risk of psychiatric disorders. BMC psychiatry. 2022 May 23;22(1):351.

Nani JV, Dal Mas C, Yonamine CM, Ota VK, Noto C, Belangero SI, Mari JJ, Bressan R, Cordeiro Q, Gadelha A, Hayashi MA. A Study in First-Episode Psychosis Patients: Does angiotensin i-converting enzyme activity associated with genotype predict symptom severity reductions after treatment with atypical antipsychotic risperidone? international journal of neuropsychopharmacology. 2020 Nov;23(11):721-30.

Nadalin S, Jakovac H, Peitl V, Karlović D, Buretić Tomljanović A. Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID-19. Molecular Medicine Reports. 2021 Aug 1;24(2):1-9.

Boulenouar H, Benhatchi H, Guermoudi F, Oumiloud AH, Rahoui A. An actualized screening of schizophrenia-associated genes. Egyptian Journal of Medical Human Genetics. 2022 Apr 16;23(1):81.

Kong LN, Shen YL, Chen YL, Chen X, Su GM, Wang JH, Xiao GB, Guo QW, Zhang JC, Fang DZ, Lin J. Insertion/deletion polymorphism at angiotensin-converting enzyme gene in PTSD individuals and their reciprocal effects on blood pressure. Clinical and Experimental Hypertension. 2022 Apr 3;44(3):208-14.

Pillinger, Toby, et al. "Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis." The British Journal of Psychiatry 211.6., 2017, 339-349.

Kanagasundaram P, Lee J, Prasad F, Costa-Dookhan KA, Hamel L, Gordon M, Remington G, Hahn MK, Agarwal SM. Pharmacological interventions to treat antipsychotic-induced dyslipidemia in schizophrenia patients: a systematic review and meta-analysis. Frontiers in psychiatry. 2021 Mar 17;12:642403.

Wójciak P, Domowicz K, Rybakowski JK. Metabolic indices in schizophrenia: Association of negative symptoms with higher HDL cholesterol in female patients. The World Journal of Biological Psychiatry. 2021 Aug 9;22(7):552-6.

João V. Nani, Camila M. Yonamine, Diego Castro Musial, Caroline Dal Mas, Jair J. Mari & Mirian A. F. Hayashi. ACE activity in blood and brain axis in an animal model for schizophrenia: Effects of dopaminergic manipulation with antipsychotics and psychostimulants, The World Journal of Biological Psychiatry, 2020, 21:1, 53-63.

Fjukstad KK, Athanasiu L, Bahrami S, O’Connell KS, van der Meer D, Bettella F, Dieset I, Steen NE, Djurovic S, Spigset O, Andreassen OA. Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study. The Pharmacogenomics Journal. 2021 Oct;21(5):574-85.

Mio M, Goldstein BI. Bipolar disorder and cardiovascular dysfunction: Mechanisms and implications. InNeurobiology of Bipolar Disorder 2021 Jan 1 (pp. 223-233). Academic Press.




DOI: https://doi.org/10.30596/bf.v8i2.8330

DOI (PDF): https://doi.org/10.30596/bf.v8i2.8330.g9822

Refbacks

  • There are currently no refbacks.


JURNAL BULETIN FARMATERA

Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.

Contact (WA): 0812-6208-2844

E-mail: jurnalpanduhusada@umsu.ac.id


 
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Statcounter View My Stats Buletin Farmatera